Picture of Microbot Medical logo

MBOT Microbot Medical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Microbot Medical Inc reports results for the quarter ended March 31 - Earnings Summary

Microbot Medical Inc MBOT.OQ reported a quarterly adjusted loss of 9 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -17 cents.  The lone analyst forecast for the quarter was for a loss of 13 cents per share.

Reported revenue was zero​; analysts expected zero.

Microbot Medical Inc's reported EPS for the quarter was a loss of 8 cents​.

Microbot Medical Inc shares had risen by 76.8% this quarter and gained 138.4% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 13.3% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Microbot Medical Inc is $9.00

This summary was machine generated from LSEG data May 16 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDINGESTIMATEACTUALBEAT, MET, MISSED
Mar. 31 2025-0.13-0.09Beat
Dec. 31 2024-0.18-0.20Missed
Sep. 30 2024-0.17-0.20Missed
Jun. 30 2024-0.17-0.17Met

Recent news on Microbot Medical

See all news